Is the Paradigm for Bifurcation Lesions Changing Once More?

Four years ago, we published a summary of the SMART-STRATEGY Study saying that, with bifurcation lesions, “less is more.”

La era del stent provisional para las bifurcaciones parece llegar a su fin

Last month, the DEFINITION Study published in the European Heart Journal suggested that things were about to change. Today, the DK-crush technique seems to have rendered both title and article obsolete.

According to this recent analysis published in J Am Coll Cardiol Intv, we should change the paradigm for bifurcation lesions to “more is more.”

The double-kissing and double-crush (DK-crush) technique was linked to fewer events driven by lower rates of revascularization. However, the rates of incidence for death, myocardial infraction, and stent thrombosis were similar to those observed with provisional stenting.

The clinical benefit of the 2-stent technique over provisional stenting was observed in bifurcation lesions with side branch lesion lengths of over 10 mm.


Read also: Two-Stent Strategy is Safer in True Bifurcation Lesions.


A total of 5711 patients from 21 randomized studies using 5 different techniques to treat bifurcation lesions (provisional stenting, T stenting, crush, culotte, and DK-crush) were analyzed. The mean follow-up was 12 months (9 to 36 months).

When considering all techniques, patients treated using the DK-crush technique had less events (odds ratio [OR]: 0.39; 95% confidence interval [CI]: 0.26 to 0.55) compared with those treated with provisional stenting.

This event reduction with DK-crush was primarily driven by lower rates of target lesion revascularization.


Read also: The Era of Provisional Stenting for Bifurcations Comes to an End.


No significant differences among techniques were observed in hard endpoints, such as cardiac death, myocardial infarction, and stent thrombosis.

Omitting DK-crush, all techniques had similar comparative results.

Original Title: Clinical Outcomes Following Coronary Bifurcation PCI Techniques. A Systematic Review and Network Meta-Analysis Comprising 5,711 Patients.

Reference: Giuseppe Di Gioia et al. J Am Coll Cardiol Intv 2020;13:1432–44. https://doi.org/10.1016/j.jcin.2020.03.054.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

CRABBIS Trial: Comparison of Different Provisional Stenting Sequences

Provisional stenting (PS) is the gold standard for percutaneous coronary intervention (PCI) in most patients with coronary bifurcation lesions (CBL). Moreover, recent studies such...

Andromeda Trial: Meta-Analysis of Drug Coated Balloon vs. DES in Small Vessel DeNovo Lesions

The use of coronary stents vs plain old balloon angioplasty (POBA), has allowed to reduce recoil and limiting flow dissection which were major limitation...

QFR vs. FFR: Is Coronary Revascularization Deferral Safe? Results from a FAVOR III Sub-Analysis

In cases of intermediate coronary lesions, functional assessment is recommended to aid the decision-making process regarding revascularization. There are several tools currently used to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...